Skip to main content
SpringerLink
Log in

Antianämika

  • Chapter
  • First Online:
Arzneiverordnungs-Report 2020

  • 2948 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • Aksan A, Işık H, Radeke HH, Dignass A, Stein J (2017) Systematic review with network meta-analysis: comparative efficacy and tolerability of different intravenous iron formulations for the treatment of iron deficiency anaemia in patients with inflammatory bowel disease. Aliment Pharmacol Ther 45:1303–1318

    Article  CAS  PubMed  Google Scholar 

  • Amato L, Addis A, Saulle R, Trotta F, Mitrova Z, Davoli M (2018) Comparative efficacy and safety in ESA biosimilars vs. originators in adults with chronic kidney disease: a systematic review and meta-analysis. J Nephrol 31:321–332

    Article  CAS  PubMed  Google Scholar 

  • Auerbach M, Henry D, Derman RJ, Achebe MM, Thomsen LL, Glaspy J (2019) A prospective, multi-center, randomized comparison of iron isomaltoside 1000 versus iron sucrose in patients with iron deficiency anemia; the FERWON-IDA trial. Am J Hematol 94:1007–1014

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bach V, Schruckmayer G, Sam I, Kemmler G, Stauder R (2014) Prevalence and possible causes of anemia in the elderly: a cross-sectional analysis of a large European university hospital cohort. Clin Interv Aging 9:1187–1196

    PubMed  PubMed Central  Google Scholar 

  • Bhandari S, Kalra PA, Berkowitz M, Belo D, Thomsen LL, Wolf M (2020) Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial. Nephrol Dial Transplant 12:gfaa11. https://doi.org/10.1093/ndt/gfaa011

    Article  Google Scholar 

  • Bohlius J, Schmidlin K, Brillant C, Schwarzer G, Trelle S, Seidenfeld J, Zwahlen M, Clarke M, Weingart O, Kluge S, Piper M, Rades D, Steensma DP, Djulbegovic B, Fey MF, Ray-Coquard I, Machtay M, Moebus V, Thomas G, Untch M, Schumacher M, Egger M, Engert A (2009) Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet 373:1532–1542

    Article  CAS  PubMed  Google Scholar 

  • Bollig C, Schell LK, Rücker G, Allert R, Motschall E, Niemeyer CM, Bassler D, Meerpohl JJ (2017) Deferasirox for managing iron overload in people with thalassaemia. Cochrane Database Syst Rev 8:CD7476

    PubMed  Google Scholar 

  • Bundesärztekammer (BÄK), Kassenärztliche Bundesvereinigung (KBV), Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2019) Nationale VersorgungsLeitlinie Chronische Herzinsuffizienz. Langfassung, 3. Aufl. https://doi.org/10.6101/AZQ/000465

    Book  Google Scholar 

  • Camaschella C (2015) Iron-deficiency anemia. N Engl J Med 372:1832–1843

    Article  PubMed  Google Scholar 

  • Cancelo-Hidalgo MJ, Castelo-Branco C, Palacios S, Haya-Palazuelos J, Ciria-Recasens M, Manasanch J, Pérez-Edo L (2013) Tolerability of different oral iron supplements: a systematic review. Curr Med Res Opin 29:291–303

    Article  CAS  PubMed  Google Scholar 

  • Cario H, Grosse R, Janßen G, Jarisch A, Strauss G, Meerpohl J, Hainmann I (2015) Leitlinie zur Diagnostik und Therapie der sekundären Eisenüberladung bei Patienten mit angeborenen Anämien. AWMF-Register, Bd. 025/029

    Google Scholar 

  • Collister D, Komenda P, Hiebert B, Gunasekara R, Xu Y, Eng F, Lerner B, Macdonald K, Rigatto C, Tangri N (2016) The effect of erythropoietin-stimulating agents on health-related quality of life in anemia of chronic kidney disease: a systematic review and meta-analysis. Ann Intern Med 164:472–478

    Article  PubMed  Google Scholar 

  • Curran MP, McCormack PL (2008) Methoxy polyethylene glycol-epeoetin beta: a review of its use in the management of anaemia associated with chronic kidney disease. Drugs 68:1139–1156

    Article  CAS  PubMed  Google Scholar 

  • Desai A, Lewis E, Solomon S, McMurray JJ, Pfeffer M (2010) Impact of erythropoiesis-stimulating agents on morbidity and mortality in patients with heart failure: an updated, post-TREAT meta-analysis. Eur J Heart Fail 12:936–942

    Article  PubMed  Google Scholar 

  • Fishbane S (2003) Safety in iron management. Am J Kidney Dis 41(5 Suppl):18–26

    Article  PubMed  Google Scholar 

  • Gao S, Ma JJ, Lu C (2014) Venous thromboembolism risk and erythropoiesis-stimulating agents for the treatment of cancer-associated anemia: a meta-analysis. Tumour Biol 35:603–613

    Article  CAS  PubMed  Google Scholar 

  • Girelli D, Ugolini S, Busti F, Marchi G, Castagna A (2018) Modern iron replacement therapy: clinical and pathophysiological insights. Int J Hematol 107:16–30

    Article  CAS  PubMed  Google Scholar 

  • Hastka J, Metzgeroth G, Gattermann N (2018) Eisenmangel und Eisenmangelanämie. Empfehlungen der Fachgesellschaft zur Diagnostik und Therapie hämatologischer und onkologischer Erkrankungen. https://www.onkopedia.com/de/onkopedia/guidelines/eisenmangel-und-eisenmangelanaemie/@@view/html/index.html

  • Hörl WH (2013) Differentiating factors between erythropoiesis-stimulating agents: an update to selection for anaemia of chronic kidney disease. Drugs 73:117–130

    Article  PubMed  Google Scholar 

  • Khoshnood B, Loane M, de Walle H, Arriola L, Addor MC, Barisic I, Beres J, Bianchi F, Dias C, Draper E, Garne E, Gatt M, Haeusler M, Klungsoyr K, Latos-Bielenska A, Lynch C, McDonnell B, Nelen V, Neville AJ, O’Mahony MT, Queisser-Luft A, Rankin J, Rissmann A, Ritvanen A, Rounding C, Sipek A, Tucker D, Verellen-Dumoulin C, Wellesley D, Dolk H (2015) Long term trends in prevalence of neural tube defects in Europe: population based study. BMJ 351:h5949

    Article  PubMed  PubMed Central  Google Scholar 

  • Kiss JE, Brambilla D, Glynn SA, Mast AE, Spencer BR, Stone M, Kleinman SH, Cable RG, National Heart, Lung, and Blood Institute (NHLBI) Recipient Epidemiology and Donor Evaluation Study-III (REDS-III) (2015) Oral iron supplementation after blood donation: a randomized clinical trial. JAMA 313:575–583

    Article  PubMed  PubMed Central  Google Scholar 

  • Koletzko B, Cremer M, Flothkötter M, Graf C, Hauner H, Hellmers C, Kersting M, Krawinkel M, Przyrembel H, Röbl-Mathieu M, Schiffner U, Vetter K, Weißenborn A, Wöckel A (2018) Ernährung und Lebensstil vor und während der Schwangerschaft – Handlungsempfehlungen des bundesweiten Netzwerks Gesund ins Leben. Geburtshilfe Frauenheilkd 78:1262–1282

    Article  PubMed  PubMed Central  Google Scholar 

  • Lee TW, Kolber MR, Fedorak RN, van Zanten SV (2012) Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis. J Crohns Colitis 6:267–275

    Article  PubMed  Google Scholar 

  • Lipp HP (2016) Eisen i.v. und die Aut-idem Problematik. Klinischer Stellenwert, Produktunterschiede und Grenzen der Austauschbarkeit. Dtsch Apothekerztg 9:64–69

    Google Scholar 

  • Locatelli F, Bárány P, Covic A, De Francisco A, Del Vecchio L, Goldsmith D, Hörl W, London G, Vanholder R, Van Biesen W, ERA-EDTA ERBP Advisory Board (2013) Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement. Nephrol Dial Transplant 28:1346–1359

    Article  CAS  PubMed  Google Scholar 

  • Meerpohl JJ, Schell LK, Rücker G, Motschall E, Fleeman N, Niemeyer CM, Bassler D (2014) Deferasirox for managing transfusional iron overload in people with sickle cell disease. Cochrane Database Syst Rev 5:CD7477

    PubMed  Google Scholar 

  • Mikhail A, Brown C, Williams JA, Mathrani V, Shrivastava R, Evans J, Isaac H, Bhandari S (2017) Renal association clinical practice guideline on Anaemia of Chronic Kidney Disease. BMC Nephrol 18:345

    Article  PubMed  PubMed Central  Google Scholar 

  • Moukalled NM, Bou-Fakhredin R, Taher AT (2018) Deferasirox: over a decade of experience in thalassemia. Mediterr J Hematol Infect Dis 10:e2018066

    Article  PubMed  PubMed Central  Google Scholar 

  • Nathell L, Gohlke A, Wohlfeil S (2020) Reported severe hypersensitivity reactions after intravenous iron administration in the European Economic Area (EEA) before and after implementation of risk minimization measures. Drug Saf 43:35–43

    Article  CAS  PubMed  Google Scholar 

  • Ngo K, Kotecha D, Walters JA, Manzano L, Palazzuoli A, van Veldhuisen DJ, Flather M (2010) Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients. Cochrane Database Syst Rev 1:CD7613

    Google Scholar 

  • O’Lone EL, Hodson EM, Nistor I, Bolignano D, Webster AC, Craig JC (2019) Parenteral versus oral iron therapy for adults and children with chronic kidney disease. Cochrane Database Syst Rev 2:CD7857

    PubMed  Google Scholar 

  • Palmer SC, Saglimbene V, Mavridis D, Salanti G, Craig JC, Tonelli M, Wiebe N, Strippoli GF (2014) Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis. Cochrane Database Syst Rev 12:CD10590

    Google Scholar 

  • Peña-Rosas JP, De-Regil LM, Garcia-Casal MN, Dowswell T (2015) Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev 7:CD4736

    Google Scholar 

  • Phrommintikul A, Haas SJ, Elsik M, Krum H (2007) Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 369:381–388

    Article  CAS  PubMed  Google Scholar 

  • Roger SD, Tio M, Park HC, Choong HL, Goh B, Cushway TR, Stevens V, Macdougall IC (2017) Intravenous iron and erythropoiesis-stimulating agents in haemodialysis: A systematic review and meta-analysis. Nephrology 22:969–976

    Article  CAS  PubMed  Google Scholar 

  • Röhrig G, Gütgemann I, Gurlit S, Jabs HU, Kolb G, Leischker A (2019) Anämie als geriatrisches Syndrom – Zusammenfassung des Symposiums der AG Anämie anlässlich der Jahrestagung der Deutschen Gesellschaft für Geriatrie 2018 in Köln. Z Gerontol Geriatr. https://doi.org/10.1007/s00391-019-01545-z

    Article  PubMed  Google Scholar 

  • Saglimbene VM, Palmer SC, Ruospo M, Natale P, Craig JC, Strippoli GF (2017) Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease. Cochrane Database Syst Rev 8:CD9904

    PubMed  Google Scholar 

  • Santiago P (2012) Ferrous versus ferric oral iron formulations for the treatment of iron deficiency: a clinical overview. ScientificWorldJournal 2012:846824

    Article  PubMed  PubMed Central  Google Scholar 

  • Tolkien Z, Stecher L, Mander AP, Pereira DI, Powell JJ (2015) Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS ONE 10:e117383

    Article  Google Scholar 

  • Wright DG, Wright EC, Narva AS, Noguchi CT, Eggers PW (2015) Association of erythropoietin dose and route of administration with clinical outcomes for patients on hemodialysis in the United States. Clin J Am Soc Nephrol 10:1822–1830

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Pharmakologie der Universität zu Köln, Gleueler Straße 24, 50924, Köln, Deutschland

    Priv. Doz. Dr. med. Jan Matthes

Authors
  1. Priv. Doz. Dr. med. Jan Matthes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jan Matthes .

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut, Universität Heidelberg, Heidelberg, Baden-Württemberg, Germany

    Ulrich Schwabe

  2. Arzneimittelkommission der deutschen Ärzteschaft, Berlin, Berlin, Germany

    Wolf-Dieter Ludwig

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Der/die Herausgeber bzw. der/die Autor(en), exklusiv lizenziert durch Springer-Verlag GmbH, DE, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Matthes, J. (2020). Antianämika. In: Schwabe, U., Ludwig, WD. (eds) Arzneiverordnungs-Report 2020. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-62168-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-62168-4_9

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-62167-7

  • Online ISBN: 978-3-662-62168-4

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation